Dedicated to pre-empt gouty arthritis and to treat metabolic diseases by rebalancing the gut microbiome urate metabolism
Hyperuricemic patients have an altered gut microbiome that promotes disease.
Diet is the only effective non-prescription treatment.
Prescription medicines are available only to patients with expressed gout.
A therapy for hyperuricemic patients that lower serum urate levels and complemens strict diet and drugs.
Non-prescription treatment that compliment strict diet and drugs.
Oral microbiome treatments for chronic administration.
Our unfair advantage
… combining pharmaceutical and nutritional knowledge to the ‘sweet-spot´ between food and pharma…
Beo Therapeutics works selectively with a small fraction of human gut bacteria that are considered safe for human consumption. The bacteria carry the designation Qualified Presumption of Safety (QPS).
Focusing on QPS bacteria has several benefits:
- QPS approved bacteria can be fast-tracked into human clinical studies under food-supplement regulation (non-IND study). This approach reduces cost and timelines to clinical PoC.
- QPS products can be commercialised as food-supplements, medical foods or as (non-) prescription drugs. The multiple options reduce product development risk.